Benitec Biopharma Inc. (BNTC) stock
BNTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$8.15−0.39 (-4.57%)
Close on Nov 17, 2026Market cap $284.29MP/E –Yield –
Benitec Biopharma enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Benitec Biopharma's enterprise value was $145.96M on Nov 11, 2026, against $245.73M a year earlier. Over the last 5 years it ranged from $2.37M to $1.62B, with a median of $226.76M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $145.96M | -43.7% |
| 2025 | Dec 31, 2025 | $259.11M | -72.7% |
| 2024 | Dec 31, 2024 | $949.09M | +8412.0% |
| 2023 | Dec 29, 2023 | $11.15M | -96.5% |
| 2022 | Dec 30, 2022 | $319.13M | -80.3% |
| 2021 | Dec 31, 2021 | $1.62B | +556.9% |
| 2020 | Dec 31, 2020 | $246.94M | -49.2% |
| 2019 | Dec 31, 2019 | $485.71M | – |
See a number that looks wrong?